Arrowhead Research ARWR Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Arrowhead Research in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arrowhead Research's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arrowhead Research's financing cash flow?
- Arrowhead Research (ARWR) reported financing cash flow of $795.72M in Q1 2026.
- How has Arrowhead Research's financing cash flow changed year-over-year?
- Arrowhead Research's financing cash flow increased by 761.3% year-over-year, from $92.38M to $795.72M.
- What is the long-term trend for Arrowhead Research's financing cash flow?
- Over 3 years (2021 to 2024), Arrowhead Research's financing cash flow has grown at a 325.4% compound annual growth rate (CAGR), from $11.31M to $870.52M.
- What does financing cash flow mean?
- The net change in cash resulting from financing activities.
- How do you interpret financing cash flow?
- Positive values indicate net capital raising, while negative values indicate debt repayment or capital returns to shareholders.
- How does financing cash flow compare across companies?
- Highly variable across the biotech sector depending on the stage of the company's clinical pipeline.